Inactive Instrument

Highlights POIT BIOP

Equities

RACA

US7305411099

Highlights

Unlock all the news: Be the first to know and act before the market!

Fusion Pharmaceuticals an 'Attractive' Takeover Target Following Recent Radiopharma Deals, Oppenheimer Says	Dec. 27	MT
Eli Lilly: successful takeover bid for POINT Biopharma Global	Dec. 27	CF
Eli Lilly Completes Acquisition of Point Biopharma Global	Dec. 27	MT
Eli Lilly Closes $1.4 Billion Takeover of Point Biopharma	Dec. 27	MT
Eli Lilly and Company completed the acquisition of POINT Biopharma Global Inc. from Joe A. McCann, Allan Charles Silber, Neil E. Fleshner and others.	Dec. 26	CI
Eli Lilly Extends Tender Offer for POINT Biopharma Acquisition to Dec. 22	Dec. 18	MT
Eli Lilly: further extension of takeover bid for Point Biopharma Global	Dec. 18	CF
Lantheus Holdings, Inc. and POINT Biopharma Global Inc. Announce Positive Topline Results from Pivotal Splash Trial in Metastatic Castration-Resistant Prostate Cancer	Dec. 18	CI
Eli Lilly Further Extends Tender Offer Deadline for Point Biopharma Shares	Dec. 18	MT
Eli Lilly: further extension of its tender offer for POINT Biopharma	Dec. 04	CF
Eli Lilly Extends Tender Offer for POINT Biopharma to Dec. 15	Dec. 04	MT
Eli Lilly Extends Tender Offer Period for Point Biopharma Global Acquisition	Dec. 04	MT
Eli Lilly extends tender offer to buy Point Biopharma	Dec. 04	RE
Eli Lilly: has extended its tender offer for Point Biopharma	Nov. 20	CF
Eli Lilly Extends Tender Offer for POINT Biopharma Acquisition	Nov. 17	MT
Point Biopharma Holders Resisting Eli Lilly Tender Offer	Nov. 17	DJ
Eli Lilly Extends Tender Offer for Point Biopharma Acquisition at $12.50 a Share to Dec. 1	Nov. 17	MT
Eli Lilly Extends Tender Offer for Point Biopharma	Nov. 17	MT
Lilly extends tender offer to acquire Point Biopharma to Dec 1	Nov. 17	RE
Eli Lilly Gets Approval for Indirect Transfer of Control of POINT's Radioactive Materials License	Nov. 15	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights POIT BIOP

Equities

RACA

US7305411099

Highlights

Filters